Ease-of-use study of pirbuterol acetate in the Autohaler actuator in three countries: the United States, Germany, and France.
The preferred form of acute bronchodilator therapy is to administer aerosolized beta-agonist by a metered-dose inhaler. Many patients cannot use this device efficiently, the major problem being coordination of dose release with inspiration. A new breath-actuated inhaler (the Autohaler actuator) has been developed to overcome this problem. The objective of this study was to evaluate patient's and staff's perceptions of this device. Ninety-eight percent of patients rated the device easy to use and 83% rated the overall use as excellent or good. The staffs rated it as excellent or good for 93% of patients. It was concluded that patients would accept this device, and greater patient compliance could be realized.
Bronsky
E A
EA
Intermountain Allergy and Asthma Clinic, Salt Lake City, Utah 84102.
Debelic
M
M
Pujet
J C
JC
Hahn
M
M
D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004983:Ethanolamines / Q000008:administration & dosage* / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D005602:France; D005858:Germany; D006801:Humans; D008297:Male; D008875:Middle Aged; D009330:Nebulizers and Vaporizers; D017060:Patient Satisfaction; D014481:United States
D001993:Bronchodilator Agents; D004983:Ethanolamines; C009118:pirbuterol